690 related articles for article (PubMed ID: 17483367)
21. A role for immature myeloid cells in immune senescence.
Enioutina EY; Bareyan D; Daynes RA
J Immunol; 2011 Jan; 186(2):697-707. PubMed ID: 21148798
[TBL] [Abstract][Full Text] [Related]
22. The efficacy of an IL-1alpha vaccine depends on IL-1RI availability and concomitant myeloid-derived suppressor cell reduction.
Weiss T; Vitacolonna M; Zöller M
J Immunother; 2009; 32(6):552-64. PubMed ID: 19483654
[TBL] [Abstract][Full Text] [Related]
23. Macrophages are more potent immune suppressors ex vivo than immature myeloid-derived suppressor cells induced by metastatic murine mammary carcinomas.
Hamilton MJ; Bosiljcic M; Lepard NE; Halvorsen EC; Ho VW; Banáth JP; Krystal G; Bennewith KL
J Immunol; 2014 Jan; 192(1):512-22. PubMed ID: 24285836
[TBL] [Abstract][Full Text] [Related]
24. Aptamer-mediated blockade of IL4Rα triggers apoptosis of MDSCs and limits tumor progression.
Roth F; De La Fuente AC; Vella JL; Zoso A; Inverardi L; Serafini P
Cancer Res; 2012 Mar; 72(6):1373-83. PubMed ID: 22282665
[TBL] [Abstract][Full Text] [Related]
25. Role of the prostaglandin E2 receptor in mammary tumor metastasis.
Fulton AM; Zhang SZ; Chong YC
Cancer Res; 1991 Apr; 51(8):2047-50. PubMed ID: 1849040
[TBL] [Abstract][Full Text] [Related]
26. The growing diversity and spectrum of action of myeloid-derived suppressor cells.
Mantovani A
Eur J Immunol; 2010 Dec; 40(12):3317-20. PubMed ID: 21110315
[TBL] [Abstract][Full Text] [Related]
27. Cimetidine suppresses lung tumor growth in mice through proapoptosis of myeloid-derived suppressor cells.
Zheng Y; Xu M; Li X; Jia J; Fan K; Lai G
Mol Immunol; 2013 May; 54(1):74-83. PubMed ID: 23220070
[TBL] [Abstract][Full Text] [Related]
28. Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression.
Bunt SK; Sinha P; Clements VK; Leips J; Ostrand-Rosenberg S
J Immunol; 2006 Jan; 176(1):284-90. PubMed ID: 16365420
[TBL] [Abstract][Full Text] [Related]
29. Prostaglandin E2 receptor subtype 2 (EP2) null mice are protected against murine lung tumorigenesis.
Keith RL; Geraci MW; Nana-Sinkam SP; Breyer RM; Hudish TM; Meyer AM; Malkinson AM; Dwyer-Nield LD
Anticancer Res; 2006; 26(4B):2857-61. PubMed ID: 16886605
[TBL] [Abstract][Full Text] [Related]
30. Cooperation of adenosine and prostaglandin E2 (PGE2) in amplification of cAMP-PKA signaling and immunosuppression.
Su Y; Huang X; Raskovalova T; Zacharia L; Lokshin A; Jackson E; Gorelik E
Cancer Immunol Immunother; 2008 Nov; 57(11):1611-23. PubMed ID: 18327580
[TBL] [Abstract][Full Text] [Related]
31. Myeloid-derived suppressor cells: characterization and expansion in models of endotoxemia and transplantation.
Van Rompaey N; Le Moine A
Methods Mol Biol; 2011; 677():169-80. PubMed ID: 20941610
[TBL] [Abstract][Full Text] [Related]
32. IL4Ralpha+ myeloid-derived suppressor cell expansion in cancer patients.
Mandruzzato S; Solito S; Falisi E; Francescato S; Chiarion-Sileni V; Mocellin S; Zanon A; Rossi CR; Nitti D; Bronte V; Zanovello P
J Immunol; 2009 May; 182(10):6562-8. PubMed ID: 19414811
[TBL] [Abstract][Full Text] [Related]
33. Muscarinic receptors autoantibodies purified from mammary adenocarcinoma-bearing mice sera stimulate tumor progression.
Fiszman G; Cattaneo V; de la Torre E; Español A; Colombo L; Sacerdote de Lustig E; Sales ME
Int Immunopharmacol; 2006 Aug; 6(8):1323-30. PubMed ID: 16782546
[TBL] [Abstract][Full Text] [Related]
34. Skewing the Th cell phenotype toward Th1 alters the maturation of tumor-infiltrating mononuclear phagocytes.
Nonaka K; Saio M; Suwa T; Frey AB; Umemura N; Imai H; Ouyang GF; Osada S; Balazs M; Adany R; Kawaguchi Y; Yoshida K; Takami T
J Leukoc Biol; 2008 Sep; 84(3):679-88. PubMed ID: 18566103
[TBL] [Abstract][Full Text] [Related]
35. Molecular and pharmacological blockade of the EP4 receptor selectively inhibits both proliferation and invasion of human inflammatory breast cancer cells.
Robertson FM; Simeone AM; Mazumdar A; Shah AH; McMurray JS; Ghosh S; Cristofanilli M
J Exp Ther Oncol; 2008; 7(4):299-312. PubMed ID: 19227010
[TBL] [Abstract][Full Text] [Related]
36. CpG blocks immunosuppression by myeloid-derived suppressor cells in tumor-bearing mice.
Zoglmeier C; Bauer H; Noerenberg D; Wedekind G; Bittner P; Sandholzer N; Rapp M; Anz D; Endres S; Bourquin C
Clin Cancer Res; 2011 Apr; 17(7):1765-75. PubMed ID: 21233400
[TBL] [Abstract][Full Text] [Related]
37. The role of macrophage-derived IL-1 in induction and maintenance of angiogenesis.
Carmi Y; Voronov E; Dotan S; Lahat N; Rahat MA; Fogel M; Huszar M; White MR; Dinarello CA; Apte RN
J Immunol; 2009 Oct; 183(7):4705-14. PubMed ID: 19752225
[TBL] [Abstract][Full Text] [Related]
38. Myeloid-derived suppressor cells: linking inflammation and cancer.
Ostrand-Rosenberg S; Sinha P
J Immunol; 2009 Apr; 182(8):4499-506. PubMed ID: 19342621
[TBL] [Abstract][Full Text] [Related]
39. Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway.
Haile LA; von Wasielewski R; Gamrekelashvili J; Krüger C; Bachmann O; Westendorf AM; Buer J; Liblau R; Manns MP; Korangy F; Greten TF
Gastroenterology; 2008 Sep; 135(3):871-81, 881.e1-5. PubMed ID: 18674538
[TBL] [Abstract][Full Text] [Related]
40. Tumor-expressed inducible nitric oxide synthase controls induction of functional myeloid-derived suppressor cells through modulation of vascular endothelial growth factor release.
Jayaraman P; Parikh F; Lopez-Rivera E; Hailemichael Y; Clark A; Ma G; Cannan D; Ramacher M; Kato M; Overwijk WW; Chen SH; Umansky VY; Sikora AG
J Immunol; 2012 Jun; 188(11):5365-76. PubMed ID: 22529296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
